AMPHOTERICIN-B TREATMENT OF CANDIDA-ARTHRITIS IN 2 HORSES

被引:0
作者
MADISON, JB [1 ]
REID, BV [1 ]
RASKIN, RE [1 ]
机构
[1] UNIV FLORIDA,DEPT PHYSIOL SCI,GAINESVILLE,FL 32610
关键词
EQUINE SPECIES; AMPHOTERICIN B; ARTHRITIS; CANDIDA SPP;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Infectious arthritis caused by Candida spp was diagnosed in 2 horses. Source of infection was by direct inoculation in 1 horse and was presumed to be hematogenous in the other horse. On microbial culturing of synovial fluid and synovial membrane specimens, the organisms were isolated in both horses. In both horses, the joint infections resolved after IV administration of amphotericin B and joint drainage; however, 1 horse was eventually euthanatized because of signs of cervical pain and progressively worsening ataxia. Fungal organisms isolated on microbial culturing of joint specimens in horses, although uncommon, should not be dismissed as contaminants, particularly if the same organism is recovered from more than 1 specimen. Successful resolution of fungal arthritis may be achieved with appropriate antifungal treatment, combined with joint drainage.
引用
收藏
页码:338 / 341
页数:4
相关论文
共 50 条
[31]   RHINOCEREBRAL MUCORMYCOSIS - USE OF LIPOSOMAL AMPHOTERICIN-B [J].
FISHER, EW ;
TOMA, A ;
FISHER, PH ;
CHEESMAN, AD .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1991, 105 (07) :575-577
[32]   THE PHYSIOLOGICAL-EFFECTS OF INHALED AMPHOTERICIN-B [J].
DUBOIS, J ;
BARTTER, T ;
GRYN, J ;
PRATTER, MR .
CHEST, 1995, 108 (03) :750-753
[33]   COMPLEXATION OF AMPHOTERICIN-B WITH EGG PHOSPHATIDYLCHOLINE LIPOSOMES [J].
KIM, JC ;
LEE, EO ;
YANG, JW ;
CHOE, TB ;
KIM, JD .
ARCHIVES OF PHARMACAL RESEARCH, 1995, 18 (02) :84-89
[34]   FATAL TRICHOSPORONOSIS IS NOT RELATED TO TOLERANCE TO AMPHOTERICIN-B [J].
ALBALLAA, S ;
BRYCE, EA ;
ROBERTS, FJ ;
SEKHON, A .
MYCOSES, 1991, 34 (7-8) :317-318
[35]   TREATMENT AND DEVELOPMENTAL THERAPEUTICS IN ASPERGILLOSIS .1. AMPHOTERICIN-B AND ITS DERIVATIVES [J].
STGEORGIEV, V .
RESPIRATION, 1992, 59 (05) :291-302
[36]   PRACTICAL GUIDELINES FOR PREPARING AND ADMINISTERING AMPHOTERICIN-B [J].
KINTZEL, PE ;
SMITH, GH .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (05) :1156-1164
[37]   POLYSACCHARIDE-COATED LIPOSOMAL AMPHOTERICIN-B FOR THE TREATMENT OF MURINE PULMONARY CANDIDIASIS [J].
MIYAZAKI, T ;
KOHNO, S ;
SASAYAMA, K ;
INOUE, Y ;
HARA, K ;
OGASAWARA, M ;
SATO, T ;
SUNAMOTO, J .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (03) :483-490
[38]   A RANDOMIZED TRIAL OF AMPHOTERICIN-B ALONE OR IN COMBINATION WITH ITRACONAZOLE IN THE TREATMENT OF MUCOCUTANEOUS LEISHMANIASIS [J].
RODRIGUEZ, LV ;
DEDET, JP ;
PAREDES, V ;
MENDOZA, C ;
CARDENAS, F .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1995, 90 (04) :525-528
[39]   PULMONARY INVASIVE ASPERGILLOSIS - INTEREST OF A TREATMENT WITH AMPHOTERICIN-B GIVEN IN A TRIGLYCERIDIC EMULSION [J].
ANDRES, E ;
LIMACHER, JM ;
BERGERAT, JP .
REVUE DE MEDECINE INTERNE, 1994, 15 (04) :244-249
[40]   THE EFFECT OF SURFACTANTS ON THE AGGREGATION STATE OF AMPHOTERICIN-B [J].
TANCREDE, P ;
BARWICZ, J ;
JUTRAS, S ;
GRUDA, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1030 (02) :289-295